Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of Sunday, August 30, 2026.
PS RATIO
N/A
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | 7.31 | 6.96 | 7.02 | 7.02 |
| NRC Health (NRC)vs › | $492.43M | 3.44 | 2.79 | 3.80 | 5.06 |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | 0.47 | 0.49 | 0.69 | 2.11 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 0.61 | 0.65 | 1.09 | 1.54 |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 5.39 | 7.42 | 9.93 | 15.20 |
| Doximity, Inc. (DOCS)vs › | $5.00B | 7.79 | 12.17 | 14.82 | 20.23 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 3.44 | 3.14 | 3.68 | 3.61 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | 2.59 | 3.69 | 4.22 | 4.13 |
| Chemed Corporation (CHE)vs › | $6.84B | 2.71 | 2.49 | 3.26 | 3.38 |
P/S Ratio
N/A
Market Cap / Annual Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
